25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Pure Bioscience Inc
Buy, Hold or Sell?

Let's analyze Pure Bioscience Inc together

I guess you are interested in Pure Bioscience Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Pure Bioscience Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Pure Bioscience Inc

I send you an email if I find something interesting about Pure Bioscience Inc.

1. Quick Overview

1.1. Quick analysis of Pure Bioscience Inc (30 sec.)










1.2. What can you expect buying and holding a share of Pure Bioscience Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.03
Expected worth in 1 year
$-0.05
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$-0.03
Return On Investment
-31.7%

For what price can you sell your share?

Current Price per Share
$0.09
Expected price per share
$0.07 - $0.16
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Pure Bioscience Inc (5 min.)




Live pricePrice per Share (EOD)
$0.09
Intrinsic Value Per Share
$-0.29 - $-0.16
Total Value Per Share
$-0.31 - $-0.19

2.2. Growth of Pure Bioscience Inc (5 min.)




Is Pure Bioscience Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$2.8m$1.6m-$3.3m-198.2%

How much money is Pure Bioscience Inc making?

Current yearPrevious yearGrowGrow %
Making money-$837.5k-$990.2k$152.7k18.2%
Net Profit Margin-190.7%-216.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Pure Bioscience Inc (5 min.)




2.4. Comparing to competitors in the Household & Personal Products industry (5 min.)




  Industry Rankings (Household & Personal Products)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Pure Bioscience Inc?

Welcome investor! Pure Bioscience Inc's management wants to use your money to grow the business. In return you get a share of Pure Bioscience Inc.

First you should know what it really means to hold a share of Pure Bioscience Inc. And how you can make/lose money.

Speculation

The Price per Share of Pure Bioscience Inc is $0.0885. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pure Bioscience Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pure Bioscience Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.03. Based on the TTM, the Book Value Change Per Share is $-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pure Bioscience Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.01-7.6%-0.01-8.5%-0.01-10.0%-0.01-6.6%-0.01-14.0%
Usd Book Value Change Per Share-0.01-7.3%-0.01-7.9%-0.01-9.2%0.00-2.0%0.00-0.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-7.3%-0.01-7.9%-0.01-9.2%0.00-2.0%0.00-0.7%
Usd Price Per Share0.08-0.09-0.12-0.38-0.60-
Price to Earnings Ratio-2.96--2.84--3.38--14.46-12.41-
Price-to-Total Gains Ratio-12.46--12.18--14.79-125.66-166.08-
Price to Book Ratio-3.12--9.86-14.60-14.09-30.00-
Price-to-Total Gains Ratio-12.46--12.18--14.79-125.66-166.08-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0885
Number of shares11299
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (11299 shares)-79.19-20.48
Gains per Year (11299 shares)-316.78-81.90
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-317-3270-82-92
20-634-6440-164-174
30-950-9610-246-256
40-1267-12780-328-338
50-1584-15950-410-420
60-1901-19120-491-502
70-2217-22290-573-584
80-2534-25460-655-666
90-2851-28630-737-748
100-3168-31800-819-830

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%2.018.00.010.0%3.037.00.07.5%9.0102.01.08.0%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%5.015.00.025.0%13.027.00.032.5%37.074.01.033.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.0112.00.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%5.015.00.025.0%13.027.00.032.5%37.074.01.033.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Pure Bioscience Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.006-0.007+9%-0.008+27%-0.002-72%-0.001-90%
Book Value Per Share---0.026-0.015-41%0.015-274%0.017-254%0.017-254%
Current Ratio--1.0981.672-34%3.440-68%3.096-65%2.768-60%
Debt To Asset Ratio--4.5012.805+60%0.384+1073%0.786+473%0.640+603%
Debt To Equity Ratio----0%1.655-100%0.544-100%1.314-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.007-0.007+11%-0.009+31%-0.006-13%-0.012+83%
Free Cash Flow Per Share---0.005-0.006+7%-0.007+41%-0.004-20%-0.007+38%
Free Cash Flow To Equity Per Share---0.001-0.002+101%-0.005+528%0.003-128%0.004-121%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.160--------
Intrinsic Value_10Y_min---0.288--------
Intrinsic Value_1Y_max---0.024--------
Intrinsic Value_1Y_min---0.029--------
Intrinsic Value_3Y_max---0.065--------
Intrinsic Value_3Y_min---0.088--------
Intrinsic Value_5Y_max---0.100--------
Intrinsic Value_5Y_min---0.147--------
Market Cap9899256.000+10%8948517.8409507800.205-6%13422720.000-33%42505288.041-79%67052922.141-87%
Net Profit Margin---1.595-1.907+20%-2.161+36%-1.563-2%-5.147+223%
Operating Margin---1.485-1.820+23%-2.022+36%-1.508+2%-2.521+70%
Operating Ratio--2.3482.786-16%3.022-22%2.501-6%4.782-51%
Pb Ratio-3.456-11%-3.124-9.863+216%14.602-121%14.091-122%29.996-110%
Pe Ratio-3.274-11%-2.959-2.839-4%-3.382+14%-14.462+389%12.412-124%
Price Per Share0.089+10%0.0800.085-6%0.120-33%0.380-79%0.599-87%
Price To Free Cash Flow Ratio-4.173-11%-3.773-3.881+3%-3.962+5%-19.153+408%-19.733+423%
Price To Total Gains Ratio-13.787-11%-12.463-12.183-2%-14.786+19%125.656-110%166.080-108%
Quick Ratio--0.8831.425-38%2.927-70%2.604-66%2.356-63%
Return On Assets---0.924-0.776-16%-0.433-53%-0.354-62%-0.427-54%
Return On Equity----0%-1.3340%-0.4310%-0.8360%
Total Gains Per Share---0.006-0.007+9%-0.008+27%-0.002-72%-0.001-90%
Usd Book Value---2864000.000-1678500.000-41%1648500.000-274%1856550.000-254%1855275.000-254%
Usd Book Value Change Per Share---0.006-0.007+9%-0.008+27%-0.002-72%-0.001-90%
Usd Book Value Per Share---0.026-0.015-41%0.015-274%0.017-254%0.017-254%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.007-0.007+11%-0.009+31%-0.006-13%-0.012+83%
Usd Free Cash Flow---593000.000-632750.000+7%-837000.000+41%-472750.000-20%-818325.000+38%
Usd Free Cash Flow Per Share---0.005-0.006+7%-0.007+41%-0.004-20%-0.007+38%
Usd Free Cash Flow To Equity Per Share---0.001-0.002+101%-0.005+528%0.003-128%0.004-121%
Usd Market Cap9899256.000+10%8948517.8409507800.205-6%13422720.000-33%42505288.041-79%67052922.141-87%
Usd Price Per Share0.089+10%0.0800.085-6%0.120-33%0.380-79%0.599-87%
Usd Profit---756000.000-837500.000+11%-990250.000+31%-656000.000-13%-1384425.000+83%
Usd Revenue--474000.000490750.000-3%469250.000+1%826850.000-43%601725.000-21%
Usd Total Gains Per Share---0.006-0.007+9%-0.008+27%-0.002-72%-0.001-90%
 EOD+6 -2MRQTTM+17 -14YOY+20 -125Y+5 -2710Y+13 -19

3.3 Fundamental Score

Let's check the fundamental score of Pure Bioscience Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.274
Price to Book Ratio (EOD)Between0-1-3.456
Net Profit Margin (MRQ)Greater than0-1.595
Operating Margin (MRQ)Greater than0-1.485
Quick Ratio (MRQ)Greater than10.883
Current Ratio (MRQ)Greater than11.098
Debt to Asset Ratio (MRQ)Less than14.501
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.924
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Pure Bioscience Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.000
Ma 20Greater thanMa 500.119
Ma 50Greater thanMa 1000.093
Ma 100Greater thanMa 2000.081
OpenGreater thanClose0.089
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Pure Bioscience Inc

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. Its technology platform contains silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. The company offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a ready-to-use hard surface disinfectant and food contact surface sanitizer and disinfectant; PURE Control, eliminates pathogens in produce, such as salmonella, e. coli, and listeria; PURE Multi-Purpose Hi-Foam Floor Cleaner Concentrate, a cleaning product for stainless steel, floors, walls, and painted areas; PURE Multi-Purpose Floor Cleaner, for sanitation in food processing plants, commercial kitchens, healthcare facilities, schools, and hospitality settings; and SILVERION, a SDC-based antimicrobial formulation for use as a raw material ingredient in the manufacturing of personal care products. It serves food processing, food service and hospitality, healthcare, facility care, transportation, and personal care industries. The company sells its products through end-use customers and third party distributors. The company was incorporated in 1992 and is based in El Cajon, California.

Fundamental data was last updated by Penke on 2024-11-09 19:05:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Pure Bioscience Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Pure Bioscience Inc to the Household & Personal Products industry mean.
  • A Net Profit Margin of -159.5% means that $-1.59 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Pure Bioscience Inc:

  • The MRQ is -159.5%. The company is making a huge loss. -2
  • The TTM is -190.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-159.5%TTM-190.7%+31.3%
TTM-190.7%YOY-216.1%+25.4%
TTM-190.7%5Y-156.3%-34.5%
5Y-156.3%10Y-514.7%+358.4%
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ-159.5%5.9%-165.4%
TTM-190.7%5.2%-195.9%
YOY-216.1%4.8%-220.9%
5Y-156.3%4.6%-160.9%
10Y-514.7%6.2%-520.9%
4.3.1.2. Return on Assets

Shows how efficient Pure Bioscience Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Pure Bioscience Inc to the Household & Personal Products industry mean.
  • -92.4% Return on Assets means that Pure Bioscience Inc generated $-0.92 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Pure Bioscience Inc:

  • The MRQ is -92.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -77.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-92.4%TTM-77.6%-14.8%
TTM-77.6%YOY-43.3%-34.3%
TTM-77.6%5Y-35.4%-42.2%
5Y-35.4%10Y-42.7%+7.3%
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ-92.4%1.8%-94.2%
TTM-77.6%1.6%-79.2%
YOY-43.3%1.2%-44.5%
5Y-35.4%1.5%-36.9%
10Y-42.7%1.7%-44.4%
4.3.1.3. Return on Equity

Shows how efficient Pure Bioscience Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Pure Bioscience Inc to the Household & Personal Products industry mean.
  • 0.0% Return on Equity means Pure Bioscience Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Pure Bioscience Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-133.4%+133.4%
TTM-5Y-43.1%+43.1%
5Y-43.1%10Y-83.6%+40.5%
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.5%-3.5%
TTM-3.2%-3.2%
YOY-133.4%2.6%-136.0%
5Y-43.1%2.7%-45.8%
10Y-83.6%3.3%-86.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Pure Bioscience Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Pure Bioscience Inc is operating .

  • Measures how much profit Pure Bioscience Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Pure Bioscience Inc to the Household & Personal Products industry mean.
  • An Operating Margin of -148.5% means the company generated $-1.49  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Pure Bioscience Inc:

  • The MRQ is -148.5%. The company is operating very inefficient. -2
  • The TTM is -182.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-148.5%TTM-182.0%+33.5%
TTM-182.0%YOY-202.2%+20.2%
TTM-182.0%5Y-150.8%-31.2%
5Y-150.8%10Y-252.1%+101.3%
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ-148.5%8.7%-157.2%
TTM-182.0%8.3%-190.3%
YOY-202.2%7.1%-209.3%
5Y-150.8%7.3%-158.1%
10Y-252.1%7.8%-259.9%
4.3.2.2. Operating Ratio

Measures how efficient Pure Bioscience Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Household & Personal Products industry mean).
  • An Operation Ratio of 2.35 means that the operating costs are $2.35 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Pure Bioscience Inc:

  • The MRQ is 2.348. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.786. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.348TTM2.786-0.438
TTM2.786YOY3.022-0.236
TTM2.7865Y2.501+0.284
5Y2.50110Y4.782-2.280
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3480.997+1.351
TTM2.7861.040+1.746
YOY3.0220.997+2.025
5Y2.5010.990+1.511
10Y4.7820.977+3.805
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Pure Bioscience Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Pure Bioscience Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Household & Personal Products industry mean).
  • A Current Ratio of 1.10 means the company has $1.10 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Pure Bioscience Inc:

  • The MRQ is 1.098. The company is just able to pay all its short-term debts.
  • The TTM is 1.672. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.098TTM1.672-0.574
TTM1.672YOY3.440-1.768
TTM1.6725Y3.096-1.423
5Y3.09610Y2.768+0.327
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0981.656-0.558
TTM1.6721.662+0.010
YOY3.4401.768+1.672
5Y3.0961.710+1.386
10Y2.7681.704+1.064
4.4.3.2. Quick Ratio

Measures if Pure Bioscience Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Pure Bioscience Inc to the Household & Personal Products industry mean.
  • A Quick Ratio of 0.88 means the company can pay off $0.88 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Pure Bioscience Inc:

  • The MRQ is 0.883. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.425. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ0.883TTM1.425-0.543
TTM1.425YOY2.927-1.502
TTM1.4255Y2.604-1.179
5Y2.60410Y2.356+0.248
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8830.849+0.034
TTM1.4250.811+0.614
YOY2.9270.891+2.036
5Y2.6040.929+1.675
10Y2.3560.995+1.361
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Pure Bioscience Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Pure Bioscience Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Pure Bioscience Inc to Household & Personal Products industry mean.
  • A Debt to Asset Ratio of 4.50 means that Pure Bioscience Inc assets are financed with 450.1% credit (debt) and the remaining percentage (100% - 450.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Pure Bioscience Inc:

  • The MRQ is 4.501. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 2.805. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ4.501TTM2.805+1.696
TTM2.805YOY0.384+2.421
TTM2.8055Y0.786+2.019
5Y0.78610Y0.640+0.146
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ4.5010.441+4.060
TTM2.8050.439+2.366
YOY0.3840.441-0.057
5Y0.7860.441+0.345
10Y0.6400.438+0.202
4.5.4.2. Debt to Equity Ratio

Measures if Pure Bioscience Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Pure Bioscience Inc to the Household & Personal Products industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Pure Bioscience Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY1.655-1.655
TTM-5Y0.544-0.544
5Y0.54410Y1.314-0.770
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.783-0.783
TTM-0.783-0.783
YOY1.6550.781+0.874
5Y0.5440.805-0.261
10Y1.3140.797+0.517
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Pure Bioscience Inc generates.

  • Above 15 is considered overpriced but always compare Pure Bioscience Inc to the Household & Personal Products industry mean.
  • A PE ratio of -2.96 means the investor is paying $-2.96 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Pure Bioscience Inc:

  • The EOD is -3.274. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.959. Based on the earnings, the company is expensive. -2
  • The TTM is -2.839. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.274MRQ-2.959-0.314
MRQ-2.959TTM-2.839-0.120
TTM-2.839YOY-3.382+0.543
TTM-2.8395Y-14.462+11.623
5Y-14.46210Y12.412-26.874
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
EOD-3.27412.939-16.213
MRQ-2.95913.779-16.738
TTM-2.83915.169-18.008
YOY-3.38216.736-20.118
5Y-14.46217.506-31.968
10Y12.41220.882-8.470
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Pure Bioscience Inc:

  • The EOD is -4.173. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.773. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.881. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.173MRQ-3.773-0.401
MRQ-3.773TTM-3.881+0.108
TTM-3.881YOY-3.962+0.081
TTM-3.8815Y-19.153+15.272
5Y-19.15310Y-19.733+0.580
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
EOD-4.1736.942-11.115
MRQ-3.7737.584-11.357
TTM-3.8815.713-9.594
YOY-3.9629.673-13.635
5Y-19.1536.948-26.101
10Y-19.7338.800-28.533
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Pure Bioscience Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Household & Personal Products industry mean).
  • A PB ratio of -3.12 means the investor is paying $-3.12 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Pure Bioscience Inc:

  • The EOD is -3.456. Based on the equity, the company is expensive. -2
  • The MRQ is -3.124. Based on the equity, the company is expensive. -2
  • The TTM is -9.863. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.456MRQ-3.124-0.332
MRQ-3.124TTM-9.863+6.738
TTM-9.863YOY14.602-24.464
TTM-9.8635Y14.091-23.954
5Y14.09110Y29.996-15.905
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
EOD-3.4561.578-5.034
MRQ-3.1241.619-4.743
TTM-9.8631.650-11.513
YOY14.6021.807+12.795
5Y14.0912.120+11.971
10Y29.9962.604+27.392
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-07-31. Currency in USD. All numbers in thousands.

Summary
Total Assets818
Total Liabilities3,682
Total Stockholder Equity-2,864
 As reported
Total Liabilities 3,682
Total Stockholder Equity+ -2,864
Total Assets = 818

Assets

Total Assets818
Total Current Assets805
Long-term Assets13
Total Current Assets
Cash And Cash Equivalents 349
Net Receivables 298
Inventory 56
Other Current Assets 75
Total Current Assets  (as reported)805
Total Current Assets  (calculated)778
+/- 27
Long-term Assets
Property Plant Equipment 13
Long-term Assets  (as reported)13
Long-term Assets  (calculated)13
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities733
Long-term Liabilities2,949
Total Stockholder Equity-2,864
Total Current Liabilities
Accounts payable 601
Other Current Liabilities 132
Total Current Liabilities  (as reported)733
Total Current Liabilities  (calculated)733
+/-0
Long-term Liabilities
Long term Debt 2,949
Long-term Liabilities  (as reported)2,949
Long-term Liabilities  (calculated)2,949
+/-0
Total Stockholder Equity
Common Stock1,119
Retained Earnings -136,595
Other Stockholders Equity 132,612
Total Stockholder Equity (as reported)-2,864
Total Stockholder Equity (calculated)-2,864
+/-0
Other
Capital Stock1,119
Cash and Short Term Investments 349
Common Stock Shares Outstanding 111,856
Liabilities and Stockholders Equity 818
Net Debt 2,600
Net Invested Capital 85
Net Working Capital 72
Property Plant and Equipment Gross 1,615
Short Long Term Debt Total 2,949



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-07-312024-04-302024-01-312023-10-312023-07-312023-04-302023-01-312022-10-312022-07-312022-04-302022-01-312021-10-312021-07-312021-04-302021-01-312020-10-312020-07-312020-04-302020-01-312019-10-312019-07-312019-04-302019-01-312018-10-312018-07-312018-04-302018-01-312017-10-312017-07-312017-04-302017-01-312016-10-312016-07-312016-04-302016-01-312015-10-312015-07-312015-04-302015-01-312014-10-312014-07-312014-04-302014-01-312013-10-312013-07-312013-04-302013-01-312012-10-312012-07-312012-04-302012-01-312011-10-312011-07-312011-04-302011-01-312010-10-312010-07-312010-04-302010-01-312009-10-312009-07-312009-04-302009-01-312008-10-312008-07-312008-04-302008-01-312007-10-312007-07-312007-04-302007-01-312006-10-312006-07-312006-04-302006-01-312005-10-312005-07-312005-04-302005-01-312004-10-312004-07-312004-04-302004-01-312003-10-312003-07-312003-04-302003-01-312002-10-312002-07-312002-04-302002-01-312001-10-312001-07-312001-04-302001-01-312000-10-312000-07-312000-04-302000-01-311999-10-311999-07-311999-04-301999-01-311998-10-311998-07-311998-04-301998-01-311997-10-311997-07-311997-04-301997-01-311996-10-311996-07-311996-04-301996-01-311995-10-311989-04-30
> Total Assets 
2,500
0
0
0
800
4,700
4,400
4,000
3,600
3,300
3,400
2,500
3,000
3,400
3,600
4,100
4,000
4,600
4,700
6,275
5,160
4,900
4,707
4,778
4,067
3,843
5,693
5,451
4,540
4,548
4,276
3,900
3,627
5,602
5,561
5,347
5,482
5,517
5,549
3,255
3,314
2,595
3,069
8,814
7,965
7,080
6,358
5,841
4,862
11,838
11,467
11,340
10,941
9,429
7,622
6,361
7,649
8,988
7,704
7,100
5,994
7,566
5,494
3,927
5,148
4,415
4,228
4,057
4,458
5,672
4,127
3,505
2,062
3,286
2,413
2,451
1,859
7,096
5,561
4,180
3,261
7,827
8,553
7,608
7,562
6,402
6,108
4,908
3,829
5,207
3,973
2,800
2,575
2,540
1,777
1,710
1,932
2,230
1,468
4,786
6,323
5,766
5,286
4,846
4,303
3,555
2,789
2,118
4,484
3,699
2,530
1,824
1,825
2,250
1,086
920
818
8189201,0862,2501,8251,8242,5303,6994,4842,1182,7893,5554,3034,8465,2865,7666,3234,7861,4682,2301,9321,7101,7772,5402,5752,8003,9735,2073,8294,9086,1086,4027,5627,6088,5537,8273,2614,1805,5617,0961,8592,4512,4133,2862,0623,5054,1275,6724,4584,0574,2284,4155,1483,9275,4947,5665,9947,1007,7048,9887,6496,3617,6229,42910,94111,34011,46711,8384,8625,8416,3587,0807,9658,8143,0692,5953,3143,2555,5495,5175,4825,3475,5615,6023,6273,9004,2764,5484,5405,4515,6933,8434,0674,7784,7074,9005,1606,2754,7004,6004,0004,1003,6003,4003,0002,5003,4003,3003,6004,0004,4004,7008000002,500
   > Total Current Assets 
1,100
0
0
0
300
4,200
3,800
3,300
2,800
2,500
2,000
1,100
1,000
1,500
1,700
2,200
2,100
2,600
2,500
3,746
2,794
2,352
2,136
2,085
1,911
1,691
2,000
1,827
1,291
1,371
1,184
798
710
2,553
2,591
2,474
621
615
471
534
939
295
268
6,057
5,067
4,197
3,614
2,588
1,694
8,720
8,347
8,176
7,890
6,426
4,683
3,515
4,848
6,205
4,870
4,339
3,424
5,073
3,007
1,511
2,804
2,150
2,013
1,815
2,251
3,458
1,936
1,330
486
1,760
895
1,031
478
5,763
4,209
2,856
1,979
6,592
7,212
6,180
6,142
4,964
4,639
3,476
2,459
3,896
2,721
1,612
1,456
1,484
793
772
1,041
1,391
633
3,996
5,566
4,880
4,115
3,718
3,197
2,453
1,740
1,110
3,864
3,072
1,940
1,230
1,604
2,066
939
869
805
8058699392,0661,6041,2301,9403,0723,8641,1101,7402,4533,1973,7184,1154,8805,5663,9966331,3911,0417727931,4841,4561,6122,7213,8962,4593,4764,6394,9646,1426,1807,2126,5921,9792,8564,2095,7634781,0318951,7604861,3301,9363,4582,2511,8152,0132,1502,8041,5113,0075,0733,4244,3394,8706,2054,8483,5154,6836,4267,8908,1768,3478,7201,6942,5883,6144,1975,0676,0572682959395344716156212,4742,5912,5537107981,1841,3711,2911,8272,0001,6911,9112,0852,1362,3522,7943,7462,5002,6002,1002,2001,7001,5001,0001,1002,0002,5002,8003,3003,8004,2003000001,100
       Cash And Cash Equivalents 
300
0
0
0
0
4,000
3,200
2,700
2,000
1,300
700
300
0
0
0
200
0
0
100
1,413
1,121
614
349
520
207
102
330
210
151
122
91
53
251
146
191
13
17
41
137
163
406
61
73
5,799
4,720
3,877
3,268
2,231
736
3,671
2,739
1,644
2,024
1,048
519
2,946
4,214
5,600
4,005
3,284
2,193
3,679
1,678
310
1,794
992
626
289
877
2,450
920
410
32
1,068
236
416
86
5,331
3,908
2,530
1,321
6,055
6,706
5,405
5,194
4,064
3,893
2,714
1,640
3,229
2,129
1,018
851
776
335
340
398
904
246
2,022
3,839
3,466
2,927
2,819
2,390
1,760
1,131
511
3,391
2,452
1,485
781
1,095
1,440
632
517
349
3495176321,4401,0957811,4852,4523,3915111,1311,7602,3902,8192,9273,4663,8392,0222469043983403357768511,0182,1293,2291,6402,7143,8934,0645,1945,4056,7066,0551,3212,5303,9085,331864162361,068324109202,4508772896269921,7943101,6783,6792,1933,2844,0055,6004,2142,9465191,0482,0241,6442,7393,6717362,2313,2683,8774,7205,799736140616313741171319114625153911221512103301022075203496141,1211,413100002000003007001,3002,0002,7003,2004,0000000300
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
708
4,760
4,822
5,891
4,608
4,081
3,548
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
75
75
75
75
75
75
75
75
75
75
75
75
75
75
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000757575757575757575757575757500000000000000000000000003,5484,0814,6085,8914,8224,760708000000000000000000000000000000000000000000000000
       Net Receivables 
700
0
0
0
100
100
200
200
200
600
700
700
400
800
800
1,500
800
1,600
1,400
1,361
638
539
621
701
811
791
843
842
376
409
404
280
164
2,291
2,236
2,330
430
411
158
189
409
96
51
71
58
52
86
117
8
34
117
163
835
843
19
24
143
145
136
380
332
443
363
98
50
119
16
193
373
64
95
29
18
31
9
34
47
47
40
86
189
93
106
68
263
146
142
185
297
143
146
192
275
353
129
134
373
220
156
1,607
1,089
560
466
221
368
238
206
198
201
252
156
188
285
347
171
234
298
2982341713472851881562522011982062383682214665601,0891,607156220373134129353275192146143297185142146263681069318986404747349311829956437319316119509836344333238013614514324198438351631173481178652587151964091891584114302,3302,2362,2911642804044093768428437918117016215396381,3611,4001,6008001,500800800400700700600200200200100100000700
       Inventory 
100
0
0
0
100
0
0
0
0
100
100
100
400
500
600
400
700
800
700
712
796
889
891
824
711
621
653
588
595
537
504
374
288
113
131
131
173
164
177
116
52
86
96
128
172
213
232
241
243
233
381
339
370
432
475
443
422
430
573
497
752
874
892
914
861
850
889
901
654
864
836
781
365
430
429
387
249
231
186
207
207
219
237
320
350
348
340
348
273
274
267
275
197
209
205
195
177
162
141
282
547
733
618
568
332
312
299
301
179
239
200
149
88
104
74
74
56
567474104881492002391793012993123325686187335472821411621771952052091972752672742733483403483503202372192072071862312493874294303657818368646549018898508619148928747524975734304224434754323703393812332432412322131721289686521161771641731311311132883745045375955886536217118248918897967127008007004006005004001001001000000100000100
   > Long-term Assets 
1,400
0
0
0
500
500
600
700
800
800
1,400
1,400
2,000
1,900
1,900
1,900
1,900
2,000
2,200
2,529
2,365
2,548
2,571
2,693
2,155
2,152
3,693
3,624
3,249
3,177
3,091
3,101
2,917
3,049
2,970
2,873
4,861
4,901
5,077
2,722
2,375
2,301
2,801
2,756
2,899
2,883
2,743
3,253
3,168
3,117
3,121
3,164
3,051
3,003
2,939
2,847
2,801
2,783
2,834
2,761
2,570
2,493
2,487
2,416
2,343
2,265
2,215
2,242
2,207
2,214
2,191
2,175
1,576
1,526
1,518
1,420
1,381
1,333
1,352
1,324
1,282
1,235
1,341
1,428
1,420
1,438
1,469
1,432
1,370
1,311
1,252
1,188
1,119
1,056
984
938
891
839
835
790
757
886
1,171
1,128
1,106
1,102
1,049
1,008
620
627
590
594
221
184
147
51
13
13511471842215945906276201,0081,0491,1021,1061,1281,1718867577908358398919389841,0561,1191,1881,2521,3111,3701,4321,4691,4381,4201,4281,3411,2351,2821,3241,3521,3331,3811,4201,5181,5261,5762,1752,1912,2142,2072,2422,2152,2652,3432,4162,4872,4932,5702,7612,8342,7832,8012,8472,9393,0033,0513,1643,1213,1173,1683,2532,7432,8832,8992,7562,8012,3012,3752,7225,0774,9014,8612,8732,9703,0492,9173,1013,0913,1773,2493,6243,6932,1522,1552,6932,5712,5482,3652,5292,2002,0001,9001,9001,9001,9002,0001,4001,4008008007006005005000001,400
       Property Plant Equipment 
800
0
0
0
200
500
500
600
700
700
800
800
800
800
800
800
800
800
1,100
1,237
1,056
1,009
969
934
903
842
790
718
614
574
526
482
433
222
197
187
167
150
134
124
152
136
126
196
353
437
407
987
969
941
954
1,038
1,035
1,010
968
906
857
823
910
862
697
625
564
495
426
357
326
291
257
226
199
171
146
127
115
42
36
28
90
97
90
83
231
407
440
495
568
574
548
530
515
487
461
443
416
388
362
333
351
328
316
465
771
747
740
769
728
697
620
627
590
594
221
184
147
51
13
1351147184221594590627620697728769740747771465316328351333362388416443461487515530548574568495440407231839097902836421151271461711992262572913263574264955646256978629108238579069681,0101,0351,0389549419699874074373531961261361521241341501671871972224334825265746147187908429039349691,0091,0561,2371,100800800800800800800800800700700600500500200000800
       Intangible Assets 
100
0
0
0
0
0
0
0
0
0
0
0
0
1,000
1,100
700
700
1,000
600
1,175
1,093
1,126
1,594
1,750
1,014
1,072
2,651
2,655
2,626
2,593
2,556
2,610
2,475
2,480
2,764
2,381
2,343
2,394
2,382
2,336
2,213
2,156
2,116
2,077
2,137
2,112
2,077
2,082
2,176
2,166
2,161
2,124
2,016
1,993
1,971
1,940
1,945
1,959
1,924
1,899
1,873
1,868
1,923
1,921
1,917
1,908
1,889
1,951
1,950
1,988
1,992
2,004
1,430
1,399
1,403
1,378
1,345
1,305
1,262
1,227
1,192
1,152
1,110
1,021
980
943
901
858
822
781
737
701
658
613
568
550
529
506
484
462
441
421
400
381
366
333
321
311
0
0
0
0
0
0
0
0
0
0000000003113213333663814004214414624845065295505686136587017377818228589019439801,0211,1101,1521,1921,2271,2621,3051,3451,3781,4031,3991,4302,0041,9921,9881,9501,9511,8891,9081,9171,9211,9231,8681,8731,8991,9241,9591,9451,9401,9711,9932,0162,1242,1612,1662,1762,0822,0772,1122,1372,0772,1162,1562,2132,3362,3822,3942,3432,3812,7642,4802,4752,6102,5562,5932,6262,6552,6511,0721,0141,7501,5941,1261,0931,1756001,0007007001,1001,000000000000000100
       Long-term Assets Other 
500
0
0
0
300
0
100
100
100
100
600
600
1,200
100
0
400
400
200
500
116
216
412
8
8
238
238
252
252
9
9
9
9
9
348
10
304
2,351
2,358
2,562
261
10
10
558
483
409
334
259
184
23
11
5
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
984
938
891
839
835
0
0
0
0
0
0
0
0
-1,008
-620
-627
-590
-594
-221
0
0
0
0
0000-221-594-590-627-620-1,0080000000083583989193898400000000000000000000000000000000000000000025112318425933440948355810102612,5622,3582,35130410348999992522522382388841221611650020040040001001,2006006001001001001000300000500
> Total Liabilities 
500
0
0
0
900
400
400
400
100
200
300
500
900
1,100
1,100
1,100
1,100
1,300
800
638
556
666
562
738
607
714
1,029
1,397
1,169
1,378
1,485
1,625
2,010
2,452
2,742
2,761
3,048
3,298
3,271
1,698
353
244
374
2,667
412
251
342
522
502
276
428
373
997
853
425
630
583
592
590
765
599
1,133
1,174
1,139
940
1,375
1,881
2,287
3,640
2,593
2,385
2,599
3,053
3,075
1,523
1,156
1,842
887
828
773
878
7,592
18,457
10,547
2,539
2,845
2,205
2,445
2,539
647
699
638
1,294
584
660
530
742
877
692
1,491
1,512
906
780
938
970
828
584
550
575
699
463
569
1,553
2,633
2,407
3,066
3,682
3,6823,0662,4072,6331,5535694636995755505848289709387809061,5121,4916928777425306605841,2946386996472,5392,4452,2052,8452,53910,54718,4577,5928787738288871,8421,1561,5233,0753,0532,5992,3852,5933,6402,2871,8811,3759401,1391,1741,1335997655905925836304258539973734282765025223422514122,6673742443531,6983,2713,2983,0482,7612,7422,4522,0101,6251,4851,3781,1691,3971,0297146077385626665566388001,3001,1001,1001,1001,100900500300200100400400400900000500
   > Total Current Liabilities 
400
0
0
0
900
400
400
400
200
200
300
400
800
1,200
1,100
1,100
1,100
1,300
800
638
556
666
562
738
607
714
1,029
1,397
1,169
778
1,485
1,625
2,010
2,406
2,696
2,719
3,003
3,250
3,214
1,652
353
244
374
319
412
251
342
522
502
276
416
359
981
836
406
610
563
573
571
748
583
1,118
1,162
1,131
934
1,373
1,870
2,284
3,637
2,590
1,170
1,539
2,153
2,332
1,513
1,156
1,829
875
817
763
869
7,584
18,450
10,542
2,536
2,842
2,192
2,433
2,528
637
682
623
1,281
572
650
523
738
877
692
1,491
1,512
906
780
938
970
828
584
550
575
699
463
569
532
806
545
666
733
7336665458065325694636995755505848289709387809061,5121,4916928777385236505721,2816236826372,5282,4332,1922,8422,53610,54218,4507,5848697638178751,8291,1561,5132,3322,1531,5391,1702,5903,6372,2841,8701,3739341,1311,1621,1185837485715735636104068369813594162765025223422514123193742443531,6523,2143,2503,0032,7192,6962,4062,0101,6251,4857781,1691,3971,0297146077385626665566388001,3001,1001,1001,1001,200800400300200200400400400900000400
       Short-term Debt 
200
0
0
0
400
0
0
0
0
0
100
200
300
500
600
700
400
600
400
260
211
196
196
200
0
300
400
519
500
0
600
600
781
1,245
1,375
1,405
1,435
1,435
1,525
660
0
0
0
0
0
0
0
0
0
0
0
0
126
284
0
0
0
9
9
9
0
0
0
0
0
0
0
0
962
0
86
231
368
503
54
10
332
10
5
4
4
6,969
17,618
9,802
1,802
1,961
1,494
1,641
1,853
0
0
0
503
0
0
0
0
0
0
0
0
0
0
239
239
239
0
0
0
0
0
0
0
0
0
0
0
0000000000023923923900000000005030001,8531,6411,4941,9611,8029,80217,6186,969445103321054503368231860962000000009990002841260000000000006601,5251,4351,4351,4051,3751,2457816006000500519400300020019619621126040060040070060050030020010000000400000200
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,494
1,641
1,853
0
0
0
0
0
0
0
0
0
0
0
0
0
0
239
239
239
0
0
0
0
0
0
0
0
0
0
0
00000000000239239239000000000000001,8531,6411,49400000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
200
0
0
0
200
0
200
200
100
200
200
200
500
700
500
400
600
700
400
322
309
414
319
480
544
351
521
722
591
693
798
863
1,079
981
916
870
974
1,134
955
626
192
104
131
126
334
129
255
424
423
165
312
228
596
297
232
381
368
416
347
451
329
450
531
917
676
1,025
1,538
1,875
1,946
2,094
621
848
1,134
771
629
529
1,096
510
510
533
560
384
582
522
479
654
424
574
426
425
449
486
608
420
525
386
553
749
589
1,286
1,344
773
617
557
593
465
425
416
488
561
347
432
422
652
409
506
601
6015064096524224323475614884164254655935576177731,3441,2865897495533865254206084864494254265744246544795225823845605335105101,0965296297711,1348486212,0941,9461,8751,5381,0256769175314503294513474163683812322975962283121654234242551293341261311041926269551,1349748709169811,0798637986935917225213515444803194143093224007006004005007005002002002001002002000200000200
       Other Current Liabilities 
0
0
0
0
300
0
200
200
100
0
0
0
0
0
0
0
100
0
10
56
37
56
47
58
63
63
0
155
78
85
686
761
931
1,426
1,780
1,849
2,030
2,117
734
366
161
140
243
193
78
122
87
98
80
111
104
131
2
2
174
229
195
156
224
296
244
313
308
214
258
348
332
409
663
496
79
49
51
831
884
627
733
365
307
230
309
7,200
17,868
10,020
2,057
2,188
1,768
1,859
2,102
212
233
137
170
152
125
137
185
128
103
205
168
133
163
142
138
124
159
134
87
138
116
137
110
154
136
160
132
132160136154110137116138871341591241381421631331682051031281851371251521701372332122,1021,8591,7682,1882,05710,02017,8687,20030923030736573362788483151497949666340933234825821430831324429622415619522917422131104111809887122781932431401613667342,1172,0301,8491,7801,4269317616868578155063635847563756100100000000010020020003000000
   > Long-term Liabilities 
100
0
0
0
0
0
0
0
-100
0
0
100
100
-100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
600
0
0
0
45
46
42
44
47
57
46
0
0
0
2,348
0
0
0
0
0
10
12
14
16
18
19
19
19
20
19
18
16
14
12
9
6
2
11
3
3
3
1,215
1,060
900
743
10
0
13
12
11
10
9
8
7
5
3
3
13
12
11
10
17
15
13
12
10
7
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,021
1,827
1,862
2,400
2,949
2,9492,4001,8621,8271,02100000000000000047101213151710111213335789101112130107439001,0601,215333112691214161819201919191816141210000002,34800046574744424645000600000000000000000-10010010000-1000000000100
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
46
0
43
45
48
57
46
0
0
0
2,348
0
0
0
0
0
10
12
14
16
17
19
20
20
19
19
17
16
14
12
9
5
2
11
3
3
3
2
15
13
12
10
0
13
12
11
10
9
8
7
5
3
3
13
12
11
10
17
15
13
12
10
7
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000047101213151710111213335789101112130101213152333112591214161719192020191716141210000002,3480004657484543046000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
10
0
13
12
11
10
9
8
7
5
3
3
13
12
11
10
17
15
13
12
10
7
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000471012131517101112133357891011121301000000000200000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
2,000
0
0
0
-100
4,300
4,000
3,600
3,500
3,100
3,100
2,000
2,100
2,300
2,500
3,000
2,900
3,300
3,900
5,565
4,542
4,187
4,145
4,040
3,460
3,130
4,664
4,054
3,372
3,169
2,791
2,275
1,617
3,150
2,819
2,585
2,434
2,219
2,277
1,557
2,961
2,351
2,695
6,147
7,553
6,829
6,015
5,319
4,360
11,552
11,039
10,967
9,944
8,576
7,198
5,732
7,066
8,396
7,113
6,335
5,394
6,433
4,320
2,787
4,208
3,040
2,347
1,770
818
3,079
1,742
906
-991
211
890
1,295
17
6,209
4,733
3,407
2,383
235
-9,904
-2,939
5,023
3,557
3,903
2,463
1,290
4,560
3,274
2,162
1,281
1,956
1,117
1,180
1,190
1,353
776
3,295
4,811
4,860
4,506
3,908
3,333
2,727
2,205
1,568
3,909
3,000
2,067
1,255
272
-383
-1,321
-2,146
-2,864
-2,864-2,146-1,321-3832721,2552,0673,0003,9091,5682,2052,7273,3333,9084,5064,8604,8113,2957761,3531,1901,1801,1171,9561,2812,1623,2744,5601,2902,4633,9033,5575,023-2,939-9,9042352,3833,4074,7336,209171,295890211-9919061,7423,0798181,7702,3473,0404,2082,7874,3206,4335,3946,3357,1138,3967,0665,7327,1988,5769,94410,96711,03911,5524,3605,3196,0156,8297,5536,1472,6952,3512,9611,5572,2772,2192,4342,5852,8193,1501,6172,2752,7913,1693,3724,0544,6643,1303,4604,0404,1454,1874,5425,5653,9003,3002,9003,0002,5002,3002,1002,0003,1003,1003,5003,6004,0004,300-1000002,000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,700
6,900
7,400
9,881
10,128
10,213
10,665
11,110
11,620
11,670
13,620
13,608
13,976
14,253
14,475
14,698
14,758
16,948
17,207
17,407
17,834
18,100
18,689
18,362
19,317
19,317
20,581
24,670
27,545
27,688
27,883
28,062
26,520
33,108
33,511
35,008
35,436
35,626
36,389
36,389
38,499
40,485
40,624
41,201
2,783
44,474
44,592
373
400
411
445
480
67
110
110
123
126
239
259
286
295
398
402
412
420
553
602
622
649
649
627
628
631
680
681
681
683
716
717
741
768
800
800
869
871
871
873
873
873
879
879
881
1,114
1,114
1,114
1,114
1,119
1,119
1,119
1,119
1,119
1,1191,1191,1191,1191,1191,1141,1141,1141,1148818798798738738738718718698008007687417177166836816816806316286276496496226025534204124023982952862592391261231101106748044541140037344,59244,4742,78341,20140,62440,48538,49936,38936,38935,62635,43635,00833,51133,10826,52028,06227,88327,68827,54524,67020,58119,31719,31718,36218,68918,10017,83417,40717,20716,94814,75814,69814,47514,25313,97613,60813,62011,67011,62011,11010,66510,21310,1289,8817,4006,9006,7000000000000000000
   Retained Earnings -136,595-135,839-134,982-133,980-133,245-132,213-131,337-130,277-129,284-128,051-127,291-126,589-125,793-125,060-124,249-123,654-123,474-124,796-125,269-124,603-123,478-122,659-120,786-119,490-116,924-115,540-113,848-111,821-109,482-107,636-105,898-104,962-103,219-102,540-102,570-91,668-88,848-86,982-84,891-83,155-81,221-78,546-76,497-74,015-70,171-68,012-66,478-64,654-62,500-59,993-58,164-55,971-53,610-51,579-49,761-47,281-45,260-43,588-41,978-40,211-38,500-36,804-35,258-33,038-31,433-29,921-27,455-25,901-24,893-22,989-22,113-21,105-20,238-18,955-18,083-17,164-16,555-17,688-17,251-16,720-16,238-15,651-15,218-14,586-13,930-13,092-12,344-11,083-10,605-9,554-8,957-8,541-8,160-7,070-6,520-6,026-5,586-4,316-3,700-3,700-3,800-3,600-3,800-4,000-4,100-4,100-3,000-2,600-2,200-1,700-1,300-900-800000-4,100
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
58,600
0
0
0
0
0
0
0
0
77,128
79,555
80,943
88,966
89,222
89,977
90,811
91,350
92,064
98,979
107,593
107,870
109,174
109,471
110,141
115,701
116,441
117,021
117,522
120,730
121,186
123,098
123,900
125,156
125,245
127,222
127,414
127,643
127,882
128,095
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000128,095127,882127,643127,414127,222125,245125,156123,900123,098121,186120,730117,522117,021116,441115,701110,141109,471109,174107,870107,59398,97992,06491,35090,81189,97789,22288,96680,94379,55577,1280000000058,60000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
6,100
0
0
0
700
5,200
5,300
5,300
5,700
5,700
6,100
6,100
6,200
6,300
6,300
6,600
0
0
100
0
0
0
0
0
0
0
0
0
0
828
1,489
1,497
1,906
1,906
1,947
1,947
1,955
1,956
1,957
2,001
1,186
1,186
1,184
24,669
27,545
27,688
27,883
28,062
29,006
35,685
36,656
39,116
39,592
39,844
42,438
42,535
84,567
48,607
49,091
49,922
51,490
53,715
54,081
54,366
58,533
58,600
60,066
61,283
64,546
67,623
68,110
68,795
70,472
73,987
77,128
79,555
82,058
88,966
89,222
89,977
91,332
91,350
92,064
98,979
108,014
107,870
109,174
109,471
110,659
115,701
116,441
117,021
118,146
120,730
121,186
123,098
124,560
125,156
125,245
127,222
127,917
127,643
127,882
128,095
128,253
128,437
128,617
128,738
132,079
132,163
132,290
132,354
132,398
132,478
132,542
132,574
132,612
132,612132,574132,542132,478132,398132,354132,290132,163132,079128,738128,617128,437128,253128,095127,882127,643127,917127,222125,245125,156124,560123,098121,186120,730118,146117,021116,441115,701110,659109,471109,174107,870108,01498,97992,06491,35091,33289,97789,22288,96682,05879,55577,12873,98770,47268,79568,11067,62364,54661,28360,06658,60058,53354,36654,08153,71551,49049,92249,09148,60784,56742,53542,43839,84439,59239,11636,65635,68529,00628,06227,88327,68827,54524,6691,1841,1861,1862,0011,9571,9561,9551,9471,9471,9061,9061,4971,4898280000000000100006,6006,3006,3006,2006,1006,1005,7005,7005,3005,3005,2007000006,100



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-07-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,963
Cost of Revenue-811
Gross Profit1,1521,152
 
Operating Income (+$)
Gross Profit1,152
Operating Expense-4,283
Operating Income-3,191-3,131
 
Operating Expense (+$)
Research Development302
Selling General Administrative3,981
Selling And Marketing Expenses0
Operating Expense4,2834,283
 
Net Interest Income (+$)
Interest Income0
Interest Expense-155
Other Finance Cost-0
Net Interest Income-155
 
Pretax Income (+$)
Operating Income-3,191
Net Interest Income-155
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,350-3,032
EBIT - interestExpense = -3,350
-3,498
-3,195
Interest Expense155
Earnings Before Interest and Taxes (EBIT)-3,195-3,195
Earnings Before Interest and Taxes (EBITDA)-3,047
 
After tax Income (+$)
Income Before Tax-3,350
Tax Provision-0
Net Income From Continuing Ops-3,350-3,350
Net Income-3,350
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses5,094
Total Other Income/Expenses Net-159155
 

Technical Analysis of Pure Bioscience Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pure Bioscience Inc. The general trend of Pure Bioscience Inc is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pure Bioscience Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Pure Bioscience Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.09 < 0.1 < 0.16.

The bearish price targets are: 0.0878 > 0.08 > 0.07.

Tweet this
Pure Bioscience Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Pure Bioscience Inc. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Pure Bioscience Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Pure Bioscience Inc. The current macd is 0.00866003.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pure Bioscience Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Pure Bioscience Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Pure Bioscience Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Pure Bioscience Inc Daily Moving Average Convergence/Divergence (MACD) ChartPure Bioscience Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Pure Bioscience Inc. The current adx is 31.19.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Pure Bioscience Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Pure Bioscience Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Pure Bioscience Inc. The current sar is 0.15543062.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Pure Bioscience Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Pure Bioscience Inc. The current rsi is 42.00. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Pure Bioscience Inc Daily Relative Strength Index (RSI) ChartPure Bioscience Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Pure Bioscience Inc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pure Bioscience Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Pure Bioscience Inc Daily Stochastic Oscillator ChartPure Bioscience Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Pure Bioscience Inc. The current cci is -99.41184516.

Pure Bioscience Inc Daily Commodity Channel Index (CCI) ChartPure Bioscience Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Pure Bioscience Inc. The current cmo is -28.98085363.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Pure Bioscience Inc Daily Chande Momentum Oscillator (CMO) ChartPure Bioscience Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Pure Bioscience Inc. The current willr is -92.02059202.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Pure Bioscience Inc Daily Williams %R ChartPure Bioscience Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Pure Bioscience Inc.

Pure Bioscience Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Pure Bioscience Inc. The current atr is 0.01632225.

Pure Bioscience Inc Daily Average True Range (ATR) ChartPure Bioscience Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Pure Bioscience Inc. The current obv is -1,294,104.

Pure Bioscience Inc Daily On-Balance Volume (OBV) ChartPure Bioscience Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Pure Bioscience Inc. The current mfi is 64.66.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Pure Bioscience Inc Daily Money Flow Index (MFI) ChartPure Bioscience Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Pure Bioscience Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-31CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-10-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-24STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-31CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-13STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Pure Bioscience Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Pure Bioscience Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.000
Ma 20Greater thanMa 500.119
Ma 50Greater thanMa 1000.093
Ma 100Greater thanMa 2000.081
OpenGreater thanClose0.089
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Pure Bioscience Inc with someone you think should read this too:
  • Are you bullish or bearish on Pure Bioscience Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pure Bioscience Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Pure Bioscience Inc

I send you an email if I find something interesting about Pure Bioscience Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Pure Bioscience Inc.

Receive notifications about Pure Bioscience Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.